Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

2.5K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Anthelminthic Agents01:15

Anthelminthic Agents

83
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
83
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

2.8K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 spike protein does not alter plasma fibrin clots.

Blood advances·2026
Same author

Megakaryocytes Internalize and Are Activated by Immune Complexes.

Circulation research·2026
Same author

Adaption of the plasmin generation assay to enhance sensitivity to plasminogen activator inhibitor-1 and establishment of sex-specific reference values in human plasma.

Research and practice in thrombosis and haemostasis·2026
Same author

Halofuginone vs the elevated hepcidin hurdle.

Blood advances·2026
Same author

Mechanisms of thrombin inhibition by protein S and the TFPIα-fVshort-protein S complex.

Biophysical journal·2026
Same author

Structure-functionality relationship of collagen-fibrin interpenetrating hydrogels for engineered tumor-stroma models.

Acta biomaterialia·2026

Related Experiment Video

Updated: Apr 14, 2026

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
19:16

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

21.3K

Cystamine preparations exhibit anticoagulant activity.

Maria M Aleman1, Lori A Holle2, Katherine G Stember2

  • 1Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Plos One
|April 28, 2015
PubMed
Summary

Cystamine, used to study transglutaminase, was found to inhibit blood clot formation and thrombin generation. This anticoagulant activity suggests re-examining previous studies linking transglutaminase to disease pathogenesis.

More Related Videos

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

3.1K
Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.5K

Related Experiment Videos

Last Updated: Apr 14, 2026

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
19:16

The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis

Published on: March 17, 2010

21.3K
Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

3.1K
Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks
09:18

Assessing the Putative Anticryptococcal Properties of Crude and Clarified Extracts from Mollusks

Published on: December 2, 2022

1.5K

Area of Science:

  • Biochemistry
  • Hematology
  • Pharmacology

Background:

  • Transglutaminases are enzymes catalyzing protein crosslinking, crucial in various biological processes.
  • Cystamine inhibits transglutaminase activity and has been used to study its role in coagulation and inflammation.
  • Previous research suggested cystamine's effects implicated transglutaminase in disease pathogenesis.

Purpose of the Study:

  • To investigate the effects of cystamine on fibrin crosslinking and plasma clot formation.
  • To evaluate cystamine's impact on thrombin generation and coagulation factor activity.
  • To determine if cystamine possesses anticoagulant properties.

Main Methods:

  • Assessed cystamine's effect on fibrin crosslinking in vitro.
  • Measured tissue factor-triggered plasma clot formation and thrombin generation.
  • Quantified the amidolytic activity of coagulation factors (XI and thrombin) using chromogenic substrates.

Main Results:

  • Cystamine inhibited fibrin crosslinking at concentrations that also reduced plasma clot formation and thrombin generation.
  • Cystamine demonstrated inhibitory effects on the amidolytic activity of coagulation factor XI and thrombin.
  • These findings confirm cystamine's anticoagulant activity.

Conclusions:

  • Cystamine exhibits significant anticoagulant activity by inhibiting key steps in the coagulation cascade.
  • The observed anticoagulant effects of cystamine necessitate a re-evaluation of prior studies implicating transglutaminase in disease pathogenesis.
  • This study highlights the complex role of transglutaminase and cystamine in hemostasis and inflammation.